DK121857B - Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater. - Google Patents

Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater.

Info

Publication number
DK121857B
DK121857B DK294467AA DK294467A DK121857B DK 121857 B DK121857 B DK 121857B DK 294467A A DK294467A A DK 294467AA DK 294467 A DK294467 A DK 294467A DK 121857 B DK121857 B DK 121857B
Authority
DK
Denmark
Prior art keywords
alkylgona
alkyloxy
preparation
analogous process
triene derivatives
Prior art date
Application number
DK294467AA
Other languages
Danish (da)
English (en)
Inventor
D Bertin
A Pierdet
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK121857B publication Critical patent/DK121857B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK294467AA 1966-06-07 1967-06-06 Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater. DK121857B (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR64481A FR5519M (xx) 1966-06-07 1966-06-07
FR75528A FR1514122A (fr) 1966-06-07 1966-09-07 Dérivés stéroïdes substitués en position 11 à noyau a aromatique et procédé de préparation
FR86879A FR6021M (xx) 1966-06-07 1966-12-09
FR91611A FR6030M (xx) 1966-06-07 1967-01-18
FR96848A FR6182M (xx) 1966-06-07 1967-02-28
FR98154A FR1540942A (fr) 1966-06-07 1967-03-09 Dérivés stéroïdes substitués en positions 11 et 17 à noyau a aromatique et procédé de préparation

Publications (1)

Publication Number Publication Date
DK121857B true DK121857B (da) 1971-12-13

Family

ID=27546052

Family Applications (2)

Application Number Title Priority Date Filing Date
DK294467AA DK121857B (da) 1966-06-07 1967-06-06 Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater.
DK294567AA DK119925B (da) 1966-06-07 1967-06-06 Analogifremgangsmåde til fremstilling af 3,17β-dihydroxy-11β-alkyloxy-13β-alkylgona-1,3,5(10)-triener eller ethere eller estere deraf.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK294567AA DK119925B (da) 1966-06-07 1967-06-06 Analogifremgangsmåde til fremstilling af 3,17β-dihydroxy-11β-alkyloxy-13β-alkylgona-1,3,5(10)-triener eller ethere eller estere deraf.

Country Status (14)

Country Link
US (2) US3526648A (xx)
AT (3) AT301037B (xx)
BE (2) BE699394A (xx)
CH (3) CH474495A (xx)
DE (1) DE1618830C3 (xx)
DK (2) DK121857B (xx)
ES (5) ES341435A1 (xx)
FR (6) FR5519M (xx)
GB (2) GB1151404A (xx)
IL (2) IL28112A (xx)
NL (2) NL6707903A (xx)
SE (2) SE335979B (xx)
SU (2) SU483828A3 (xx)
YU (6) YU33880B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2140258B1 (xx) * 1971-06-07 1974-08-23 Roussel Uclaf
US3906096A (en) * 1971-11-23 1975-09-16 Roussel Uclaf Novel 11{62 -alkoxy steroids
FR2183555B1 (xx) * 1972-05-10 1975-06-20 Roussel Uclaf
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
FR2401173A1 (fr) * 1977-06-27 1979-03-23 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4636496A (en) * 1984-03-20 1987-01-13 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4668668A (en) * 1984-03-20 1987-05-26 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
WO2002022645A2 (en) * 2000-09-14 2002-03-21 Accelerated Pharmaceuticals, Inc. Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA3006267C (en) * 2014-11-26 2023-08-29 The Regents Of The University Of California Estrogen receptor modulators
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Also Published As

Publication number Publication date
SU483828A3 (ru) 1975-09-05
YU10968A (en) 1978-05-15
FR5519M (xx) 1967-11-06
GB1151404A (en) 1969-05-07
YU33725B (en) 1978-02-28
DE1793738B2 (de) 1975-11-27
AT301037B (de) 1972-08-25
DE1793738A1 (de) 1973-01-11
US3579545A (en) 1971-05-18
YU175867A (en) 1977-12-31
FR6021M (xx) 1968-05-13
YU54568A (en) 1978-02-28
GB1152226A (en) 1969-05-14
DE1618830A1 (de) 1972-04-13
NL6707903A (xx) 1967-12-08
DE1618829A1 (de) 1971-01-14
ES350987A1 (es) 1969-05-16
DE1618830C3 (de) 1975-02-20
DK119925B (da) 1971-03-15
CH475965A (fr) 1969-07-31
IL28113A (en) 1973-08-29
BE699393A (xx) 1967-12-04
FR1540942A (fr) 1968-10-04
US3526648A (en) 1970-09-01
FR6030M (xx) 1968-05-13
CH474495A (fr) 1969-06-30
NL6707906A (xx) 1968-03-08
ES348057A1 (es) 1969-03-01
YU33972B (en) 1978-09-08
IL28112A (en) 1973-08-29
BE699394A (xx) 1967-12-04
FR1514122A (fr) 1968-02-23
YU240867A (en) 1977-08-31
YU33883B (en) 1978-06-30
DE1618830B2 (de) 1974-07-04
YU34050B (en) 1978-10-31
YU112567A (en) 1977-12-31
YU33880B (en) 1978-06-30
SU432714A3 (xx) 1974-06-15
AT290023B (de) 1971-05-10
YU45568A (en) 1977-12-31
ES341435A1 (es) 1968-07-01
FR6182M (xx) 1968-07-15
ES344805A1 (es) 1968-11-01
SE335979B (xx) 1971-06-21
ES351368A1 (es) 1969-06-01
SE335980B (xx) 1971-06-21
CH490361A (fr) 1970-05-15
YU33882B (en) 1978-06-30
AT279815B (de) 1970-03-25

Similar Documents

Publication Publication Date Title
DK121857B (da) Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater.
DK117631B (da) Fremgangsmåde til fremstilling af 20-oxopregnan-, 20-oxo-4-pregnen- eller 20-oxo-5(6)-pregnen-(17α, 16α-d)-oxazoliner.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK116441B (da) Fremgangsmåde til fremstilling af 10,11-dihydro-dibenzo-(b,f)-thiepinderivater.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK123232B (da) Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler.
DK115617B (da) Fremgangsmåde til fremstilling af 2,2-dichlor-1,1,3,3-tetrafluorpropan.
DK119166B (da) Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater.
DK120347B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK123169B (da) Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK117420B (da) Analogifremgangsmåde til fremstilling af 12-oxygeneret-Δ<3>-A-norandrosten-2,17-dion.
DK118406B (da) Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK122080B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK124204B (da) Analogifremgangsmåde til fremstilling af derivater af 3-phenyl-2-oxo-4-thion- eller 3-phenyl-2,4-dithion-dihydrobenzoxaziner-(1,3).
DK127327B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydronaphthalen-2-on-derivater.
DK116659B (da) Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.
DK125088B (da) Fremgangsmåde til fremstilling af 8-hydroxy-13-alkylgona-1,3,5(10),9(11)-tetraener.
DK119108B (da) Fremgangsmåde til fremstilling af C-D-trans-3-hydroxy-13-alkyl-17-oxogona-1,3,5(10),6,8-pentener.
DK118025B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater.
DK116735B (da) Fremgangsmåde til fremstilling af Δ<14>-pregnen-3,21-diol-20-on-21-acylater.

Legal Events

Date Code Title Description
PBP Patent lapsed